ProShare Advisors LLC Has $29.88 Million Stock Holdings in Chemed Co. (NYSE:CHE)

ProShare Advisors LLC trimmed its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 3.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 56,400 shares of the company's stock after selling 2,317 shares during the quarter. ProShare Advisors LLC owned about 0.37% of Chemed worth $29,881,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CHE. Raymond James Financial Inc. acquired a new stake in shares of Chemed in the 4th quarter valued at approximately $42,023,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Chemed by 10.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock valued at $72,149,000 after buying an additional 13,394 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Chemed by 12.1% in the 4th quarter. Fifth Third Bancorp now owns 4,934 shares of the company's stock valued at $2,614,000 after buying an additional 531 shares during the period. Tokio Marine Asset Management Co. Ltd. acquired a new stake in shares of Chemed in the 4th quarter valued at approximately $8,138,000. Finally, Capital Insight Partners LLC increased its stake in Chemed by 5.3% in the 4th quarter. Capital Insight Partners LLC now owns 10,633 shares of the company's stock valued at $5,633,000 after purchasing an additional 539 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Price Performance

Chemed stock traded down $5.97 during mid-day trading on Thursday, hitting $565.25. 25,415 shares of the company were exchanged, compared to its average volume of 101,872. The business's 50 day simple moving average is $585.27 and its two-hundred day simple moving average is $564.84. The company has a market capitalization of $8.27 billion, a P/E ratio of 28.62, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.20 earnings per share. Equities research analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Thursday, May 29th. Chemed's dividend payout ratio is presently 9.74%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CHE shares. Royal Bank of Canada raised their price target on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Insiders Place Their Bets

In other news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president now directly owns 14,627 shares in the company, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This represents a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,500 shares of company stock worth $4,401,120 over the last quarter. 3.29% of the stock is owned by corporate insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.